insights_auto
Zašto je CMXHF skočio 2,22%?
Istražite detaljnijechevron_right
CMXHF:OTCMKTS
CSL Ltd
123,79 USD
arrow_upward
+2,22%(+2,69) 1D
15. lis, 16:00:00 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za CMXHF...
Otvori
129,22 USD
Najviša
129,22 USD
Najniža
123,79 USD
Trž. kap.
92,23 mlr.
Prosj. kol.
167,00
Količina
564,00
52-tjed. najviša
148,36 USD
52-tjed. najniža
63,84 USD
Beta
0,56
Dionice u optjecaju
479,88 mil.
Broj djelatnika
29 tis.
Otvori
129,22 USD
Najviša
129,22 USD
Najniža
123,79 USD
Trž. kap.
92,23 mlr.
Prosj. kol.
167,00
Količina
564,00
52-tjed. najviša
148,36 USD
52-tjed. najniža
63,84 USD
Beta
0,56
Dionice u optjecaju
479,88 mil.
Broj djelatnika
29 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
ad-hoc-news.de
·
prije 1 dan
CSL agrees Alentis drug deal as CSL stock has AUD 89.7 billion value
Profil
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
CSL Ltd – informacije
Glavni izvršni direktorPaul McKenzie
Zaposlenici29 tis.
Osnovano1916
SjedišteMelbourne, Victoria, Australija
Sektor-
Web-lokacijacsl.com